Home
Cogent Biosciences

Cogent Biosciences Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domaincogentbio.com

Year Founded2014

Employees51 - 200

Annual Revenue$5M - $10M

Cogent Biosciences

Cogent Biosciences (including company regionals)

cogentbio.com

See more website traffic and engagement information

Cogent Biosciences Revenue up to August 2026 is 5M - 10M

revenue generated by Cogent Biosciences top domains

Cogent Biosciences top domains revenue over 3 years

Revenue for Cogent Biosciences top domains

cogentbio.com5M - 10M

See more with Sales Intelligence

Total visits to Cogent Biosciences's top domains

Understand Cogent Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cogentbio.com16K

See more with Sales Intelligence

Avg. visit duration in Cogent Biosciences's top domains

Analyze Cogent Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cogentbio.com00:00:33

See more with Sales Intelligence

Avg. pageviews on Cogent Biosciences's top domains

See how Cogent Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cogentbio.com1.67

See more with Sales Intelligence

Cogent Biosciences top competitors by domain

Top similar sites in August 2026, ranked by their affinity

psychogenics.comCompany NamePsychoGenicsEmployees51 - 200HQUnited States, New Jersey, ParamusAnnual revenue$25M - $50MTotal visits4.6KScience and Education > Biology

Top technologies used by Cogent Biosciences

These are the website technologies, by industry, used by Cogent Biosciences top domains

Advertising (5)

DoubleClick

Content Management System (4)

WordPress

Widget (4)

Twemoji

Email Services (3)

G Suite

More Technologies

12

See all

News & Signals from Cogent Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCogent Biosciences, Inc. had valuation of $6.47B on Aug 14th '26.* Cogent shares opened at $37.31, down 4.3%, with a market capitalization of $6.47 billion.

NewsCogentbio attended event 2026 European Hematology Association (EHA) Congress on Jun 11th '26.Cogent Biosciences announces preclinical data from novel JAK2 V617F inhibitor at the 2026 European Hematology Association (EHA) Congress.

NewsCogentbio attends event 2026 american society of clinical oncology (ASCO) annual meeting.Cogent Biosciences announces oral presentation of positive phase 3 PEAK trial in gastrointestinal stromal tumors (GIST) at the 2026 american society of clinical oncology (ASCO) annual meeting.